Skip to content

Pilot Study of App-delivered Sleep Coaching Among Cancer Survivors and Their Partners

Pilot Study of App-delivered Sleep Coaching Among Cancer Survivors and Bedroom Partners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06938802
Acronym
ACCESS
Enrollment
40
Registered
2025-04-22
Start date
2025-07-21
Completion date
2025-12-16
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Sleep quality, Psycho-oncology

Brief summary

The proposed study will test the feasibility and acceptability of enrolling and retaining cancer survivors and their bedroom partners in a study evaluating digitally delivered behavioral sleep interventions.

Detailed description

Poor sleep is a common issue among cancer survivors that can persist for years and has been linked to increased symptoms (e.g., depression, fatigue), worse quality of life, and worse clinical outcomes like cancer progression and mortality. Partners of cancer survivors also experience poor sleep, but current interventions typically focus on survivors, leaving partners underrepresented. The proposed study will test the feasibility and acceptability of enrolling and retaining cancer survivors and their bedroom partners in a study evaluating digitally delivered behavioral sleep interventions.

Interventions

BEHAVIORALSleep coaching

Participants will receive an 8-week sleep coaching program delivered by smartphone/tablet app

BEHAVIORALSleep education

Participants will receive electronic access to educational information about sleep for 8 weeks

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Cancer Survivor eligibility criteria: Inclusion Criteria: 1. Diagnosed with any cancer, 2. Completed curative treatment six months to five years before enrolling (excepting ongoing adjuvant endocrine therapy), 3. Score 8 to 14 on the Insomnia Severity Index (ISI) 4. Have a consistent bedroom partner (i.e., sleep in the same bedroom 4 or more nights per week). Bedroom partner eligibility criteria: 1\) No cancer within the past five years Both survivors and bedroom partners: Inclusion: 1. Age \> or =18 years, 2. Able to speak and read English, 3. Able to provide informed consent, Exclusion: 4. No changes in type or dose of prescription sleep medications in the past three months, 5. Not engaged in behavioral sleep treatment for six months prior to enrollment, 6. Not planning to travel across 3 time zones or more during the eight intervention weeks or for the two weeks leading up to study assessments, 7. Not pregnant at enrollment or planning to become pregnant during the study, 8. No diagnosed or suspected psychiatric or medical condition that could interfere with participation, 9. No commitments that would interfere with regular night time sleep patterns (e.g., shift work), 10. No known untreated non-insomnia sleep disorders (e.g., sleep apnea, restless legs syndrome, hypersomnia, circadian rhythm sleep-wake disorder). Enrolled participants will be allowed to remain in the study even if the other member of their dyad withdraws.

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction assessed by study-specific survey after the intervention - acceptability8 weeks - Immediately after the interventionThe intervention/study will be deemed acceptable if, on average, participants report satisfaction with the overall program/study as ≥2 on a 0-4 scale.
Feasibility assessed by recruitment and retention ratesThroughout the recruitment periodThe intervention/study will be deemed feasible if 50% of eligible potential participants enroll and 75% of enrolled participants are retained at post-intervention

Secondary

MeasureTime frameDescription
Change in sleep health from baseline to immediately after the intervention8 weeks - Immediately after the interventionParticipants will complete 8-item short forms of the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance and sleep-related impairment measures at baseline and immediately after the intervention. Raw scores will be converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores on PROMIS measures indicate more of the underlying construct.
Change in insomnia symptoms from baseline to immediately after the intervention8 weeks - Immediately after the interventionParticipants will complete 7-item Insomnia Severity Index at baseline and immediately after the intervention. Scores range from 0-28 with higher scores indicating more acute symptoms of insomnia.
Change in symptom burden from baseline to immediately after the intervention8 weeks - Immediately after the interventionParticipants will complete PROMIS scales assessing fatigue, anxiety, and depression at baseline and immediately after the intervention. Raw scores will be converted to T-scores with a mean of 50 and a standard deviation of 10. Higher scores on PROMIS measures indicate more of the underlying construct.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026